developing cancer cures through the asx | going public w leslie chong & paul hopper
Published 2 months ago • 2.1K plays • Length 53:26Download video MP4
Download video MP3
Similar videos
-
7:40
imugene limited (asx: imu) emergence 2024: presentation by leslie chong, managing director and ceo
-
4:51
'the why' | imugene, developing cancer immunotherapies asx: imu
-
6:16
imugene's new cancer therapy cd19 (oncarlytics) considered the 'holy grail'
-
29:41
infinity series with imugene chairman paul hopper asx: imu
-
3:06
asx:imu - imugene managing director, leslie chong on 6pr bulls n' bears report
-
16:12
a clinical stage immuno-oncology company.
-
29:19
imugene celularity announce an exclusive strategic partnership to develop a novel oncolytic virus.
-
20:11
interview with the cf33 oncolytic virus inventor - imugene (imu)
-
20:37
imugene (asx: imu) – the ‘holy grail’ of cancer treatment…?! | asx ceo interview 🚀📈
-
26:16
a californian cancer killer professor yuman fong and his work with imugene
-
13:15
imugene ltd (asx:imu) investor presentation 2017
-
10:49
imugene growing by leaps and bounds while advancing novel technology platforms
-
4:53
imugene (asx: imu) featured on fox business 'trending today' - trailblazers in biotech
-
7:36
imugene achieves ‘complete response’ with mid dose cancer trial
-
44:28
imugene investor presentation | non-deal roadshow 2023 australia
-
0:38
resistance mechanisms associated with the use of adcs in uc
-
4:44
immutep (asx:imm) - innovative cancer therapies
-
1:24
channel 7 news exclusive: imugene licenses car t directed ov therapy for solid tumours
-
3:04
imugene progresses oncarlytics solid tumour trial to combination arm
-
6:12
imugene talks dose escalation for checkvacc's city of hope trial
-
18:36
biotech unlocked - imugene asx:imu